GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jubilant Pharmova Ltd (BOM:530019) » Definitions » E10

Jubilant Pharmova (BOM:530019) E10 : ₹39.07 (As of Jun. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Jubilant Pharmova E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Jubilant Pharmova's adjusted earnings per share data for the three months ended in Jun. 2024 was ₹30.350. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹39.07 for the trailing ten years ended in Jun. 2024.

During the past 12 months, Jubilant Pharmova's average E10 Growth Rate was 4.80% per year. During the past 3 years, the average E10 Growth Rate was 9.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Jubilant Pharmova was 9.60% per year. The lowest was -0.20% per year. And the median was 4.70% per year.

As of today (2024-09-21), Jubilant Pharmova's current stock price is ₹1206.60. Jubilant Pharmova's E10 for the quarter that ended in Jun. 2024 was ₹39.07. Jubilant Pharmova's Shiller PE Ratio of today is 30.88.

During the past 13 years, the highest Shiller PE Ratio of Jubilant Pharmova was 31.45. The lowest was 5.17. And the median was 15.02.


Jubilant Pharmova E10 Historical Data

The historical data trend for Jubilant Pharmova's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jubilant Pharmova E10 Chart

Jubilant Pharmova Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.06 27.90 25.85 35.83 36.70

Jubilant Pharmova Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.27 38.80 38.09 36.70 39.07

Competitive Comparison of Jubilant Pharmova's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Jubilant Pharmova's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jubilant Pharmova's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jubilant Pharmova's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Jubilant Pharmova's Shiller PE Ratio falls into.



Jubilant Pharmova E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jubilant Pharmova's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=30.35/155.7889*155.7889
=30.350

Current CPI (Jun. 2024) = 155.7889.

Jubilant Pharmova Quarterly Data

per share eps CPI Adj_EPS
201409 -5.910 96.780 -9.513
201412 -0.700 96.780 -1.127
201503 2.680 97.163 4.297
201506 8.280 99.841 12.920
201509 8.100 101.753 12.401
201512 7.890 102.901 11.945
201603 0.720 102.518 1.094
201606 9.630 105.961 14.158
201609 9.290 105.961 13.659
201612 7.660 105.196 11.344
201703 9.630 105.196 14.261
201706 9.940 107.109 14.458
201709 8.230 109.021 11.760
201712 13.640 109.404 19.423
201803 9.940 109.786 14.105
201806 13.000 111.317 18.194
201809 13.500 115.142 18.266
201812 16.740 115.142 22.649
201903 -6.380 118.202 -8.409
201906 11.610 120.880 14.963
201909 15.660 123.175 19.806
201912 12.770 126.235 15.760
202003 16.350 124.705 20.425
202006 5.530 127.000 6.784
202009 14.060 130.118 16.834
202012 19.460 130.889 23.162
202103 13.430 131.771 15.878
202106 10.090 134.084 11.723
202109 8.970 135.847 10.287
202112 3.200 138.161 3.608
202203 3.740 138.822 4.197
202206 2.960 142.347 3.240
202209 0.340 144.661 0.366
202212 -0.980 145.763 -1.047
202303 -6.150 146.865 -6.524
202306 0.400 150.280 0.415
202309 3.940 151.492 4.052
202312 4.200 152.924 4.279
202403 -3.690 153.035 -3.756
202406 30.350 155.789 30.350

Add all the adjusted EPS together and divide 10 will get our e10.


Jubilant Pharmova  (BOM:530019) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Jubilant Pharmova's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1206.60/39.07
=30.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Jubilant Pharmova was 31.45. The lowest was 5.17. And the median was 15.02.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Jubilant Pharmova E10 Related Terms

Thank you for viewing the detailed overview of Jubilant Pharmova's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Jubilant Pharmova Business Description

Traded in Other Exchanges
Address
1A, Sector 16A, Noida, UP, IND, 201 301
Jubilant Pharmova Ltd is an integrated global pharmaceutical company. The company's segment includes Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment. Geographically, it derives a majority of its revenue from Americas and Europe.

Jubilant Pharmova Headlines

No Headlines